About the Authors
- Rick A. Bright
-
*To whom correspondence should be addressed. E-mail: rbright@novavax.com (RB); tmr15@pitt.edu (TR)
Affiliation Novavax, Inc., Rockville, Maryland, United States of America
- Donald M. Carter
-
Affiliation Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Corey J. Crevar
-
Affiliation Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Franklin R. Toapanta
-
Affiliation Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Jonathan D. Steckbeck
-
Affiliation Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Kelly S. Cole
-
Affiliation Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Niranjan M. Kumar
-
Affiliation Novavax, Inc., Rockville, Maryland, United States of America
- Peter Pushko
-
Affiliation Novavax, Inc., Rockville, Maryland, United States of America
- Gale Smith
-
Affiliation Novavax, Inc., Rockville, Maryland, United States of America
- Terrence M. Tumpey
-
Affiliation Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Ted M. Ross
-
*To whom correspondence should be addressed. E-mail: rbright@novavax.com (RB); tmr15@pitt.edu (TR)
Affiliation Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: TR RB KC CC. Performed the experiments: TT PP DC FT JS CC. Analyzed the data: TT TR RB GS DC FT JS KC CC. Contributed reagents/materials/analysis tools: TT RB GS PP NK. Wrote the paper: TR.